<b>Conclusions</b>: Pioglitazone markedly ameliorates CLP-induced SA-AKI by suppressing TLR-4/NF-κB/TNF-α signaling and oxidative stress, improving renal structure, function, and survival. This evidence concerns the gene TNF and acute kidney injury.